A Novel Approach to Early Process Design of Therapeutic Monoclonal Antibody Production in CHO Cells Using an Optically-Based Single-Use Mini-Bioreactor Technology

Thursday, 28 June 2012 at 14:45

Add to Calendar ▼2012-06-28 14:45:002012-06-28 15:45:00Europe/LondonA Novel Approach to Early Process Design of Therapeutic Monoclonal Antibody Production in CHO Cells Using an Optically-Based Single-Use Mini-Bioreactor TechnologySELECTBIOenquiries@selectbiosciences.com

This study proposes an innovative early optimization process for biosimilar monoclonal antibodies (mAb) that combines optically-based mini-bioreactor and lectin array-based glycoanalytical technologies to optimize (mAb) titer and glycosylation, in parallel.